The supplemental New Drug Application is supported by Phase III data, which showed Caplyta significantly prolonged time to ...

While the growing oncology pipeline offers tremendous potential, the path from clinical development through to commercial ...

Ekterly becomes the first FDA-approved oral on-demand treatment for hereditary angioedema in patients aged 12 years and older ...

Biljana Naumovic, US President, oncology, solid tumor, Johnson & Johnson Innovative Medicine, outlines how the company is ...

The National Alliance on Mental Illness (NAMI) issued a response to the bill, stating that the cuts to Medicare and Medicaid ...

Traditionally, COVID vaccines have been delivered via injections. According to the Cincinnati Children’s Hospital Medical ...

Organizations like the Alzheimer’s Drug Discovery Foundation (ADDF) have always been an important part of the life sciences industry. As a venture philanthropy, it seeks out promising early-stage drug ...

Does Novo Nordisk support compounded GLP-1s? However, companies like Novo Nordisk have raised concerns when it comes to compounding. For drugs as popular as GLP-1s, there is a risk that some ...

This Peer Exchange® starts off with an introduction of the panel: Edward Ahn, CEO of MEDIPOST, Inc.; Rob Philo, Founder and CEO of Core Market Access Advisors; and Shana Gunderson Hua, PharmD, Vice ...

However, while these endpoints are generally accepted in the curative oncology space, payers continue to require a demonstrated OS improvement. In addition, the relevance of these endpoints and the ...

Immuno Cure BioTech and PharmaJet are working together on a clinical study to test the effectiveness of PharmaJet’s needle-free vaccine delivery system for Immuno Cure’s HIV therapeutic DNA vaccine.

In an interview with Pharmaceutical Executive, Pedro Valencia, VP, asset strategy leadership, oncology, AbbVie, discussed the company’s expanding efforts in solid tumors, a space where it is still ...